Alnylam Pharmaceuticals
ALNY
#618
Rank
NZ$54.59 B
Marketcap
$421.84
Share price
3.69%
Change (1 day)
74.90%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company